 | • レポートコード：QY2112C03885 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はミカファンギン薬剤の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ミカファンギン薬剤の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（使い捨て式バイアル50mg、使い捨て式バイアル100mg）、用途別市場規模（カンジダ血症、呼吸器真菌症、消化管真菌症）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ミカファンギン薬剤の世界市場概要 ・メーカー別の競争状況、市場シェア ・ミカファンギン薬剤の種類別市場規模：使い捨て式バイアル50mg、使い捨て式バイアル100mg ・ミカファンギン薬剤の用途別市場規模：カンジダ血症、呼吸器真菌症、消化管真菌症 ・北米のミカファンギン薬剤市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのミカファンギン薬剤市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのミカファンギン薬剤市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のミカファンギン薬剤市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのミカファンギン薬剤市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Astellas、Endo International、Xellia Pharmaceuticals、Teva、Hikma、Jiangsu Hansoh Pharmaceutical、Apotex ・ミカファンギン薬剤のバリューチェーン・販売チャネル分析 ・ミカファンギン薬剤の世界市場動向 |
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis.
Market Analysis and Insights: Global Micafungin Drug Market
The global Micafungin Drug market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
Global Micafungin Drug Scope and Segment
Micafungin Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Micafungin Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
50 mg Single-use Vial
100 mg Single-use Vial
Segment by Application
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
By Company
Astellas
Endo International
Xellia Pharmaceuticals
Teva
Hikma
Jiangsu Hansoh Pharmaceutical
Apotex
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Micafungin Drug Product Introduction
1.2 Market by Type
1.2.1 Global Micafungin Drug Market Size Growth Rate by Type
1.2.2 50 mg Single-use Vial
1.2.3 100 mg Single-use Vial
1.3 Market by Application
1.3.1 Global Micafungin Drug Market Size Growth Rate by Application
1.3.2 Candidemia
1.3.3 Respiratory Mycosis
1.3.4 Gastrointestinal Mycosis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Micafungin Drug Sales Estimates and Forecasts 2016-2027
2.2 Global Micafungin Drug Revenue Estimates and Forecasts 2016-2027
2.3 Global Micafungin Drug Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Micafungin Drug Regions by Sales
2.4.1 Global Top Micafungin Drug Regions by Sales (2016-2021)
2.4.2 Global Top Micafungin Drug Regions by Sales (2022-2027)
2.5 Global Top Micafungin Drug Regions by Revenue
2.5.1 Global Top Micafungin Drug Regions by Revenue (2016-2021)
2.5.2 Global Top Micafungin Drug Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Micafungin Drug Sales by Manufacturers
3.1.1 Global Top Micafungin Drug Manufacturers by Sales (2016-2021)
3.1.2 Global Top Micafungin Drug Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Micafungin Drug Sales in 2020
3.2 Global Micafungin Drug Revenue by Manufacturers
3.2.1 Global Top Micafungin Drug Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Micafungin Drug Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Micafungin Drug Revenue in 2020
3.3 Global Micafungin Drug Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Micafungin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Micafungin Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Micafungin Drug Sales by Type
4.1.1 Global Micafungin Drug Historical Sales by Type (2016-2021)
4.1.2 Global Micafungin Drug Forecasted Sales by Type (2022-2027)
4.1.3 Global Micafungin Drug Sales Market Share by Type (2016-2027)
4.2 Global Micafungin Drug Revenue by Type
4.2.1 Global Micafungin Drug Historical Revenue by Type (2016-2021)
4.2.2 Global Micafungin Drug Forecasted Revenue by Type (2022-2027)
4.2.3 Global Micafungin Drug Revenue Market Share by Type (2016-2027)
4.3 Global Micafungin Drug Price by Type
4.3.1 Global Micafungin Drug Price by Type (2016-2021)
4.3.2 Global Micafungin Drug Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Micafungin Drug Sales by Application
5.1.1 Global Micafungin Drug Historical Sales by Application (2016-2021)
5.1.2 Global Micafungin Drug Forecasted Sales by Application (2022-2027)
5.1.3 Global Micafungin Drug Sales Market Share by Application (2016-2027)
5.2 Global Micafungin Drug Revenue by Application
5.2.1 Global Micafungin Drug Historical Revenue by Application (2016-2021)
5.2.2 Global Micafungin Drug Forecasted Revenue by Application (2022-2027)
5.2.3 Global Micafungin Drug Revenue Market Share by Application (2016-2027)
5.3 Global Micafungin Drug Price by Application
5.3.1 Global Micafungin Drug Price by Application (2016-2021)
5.3.2 Global Micafungin Drug Price Forecast by Application (2022-2027)
6 North America
6.1 North America Micafungin Drug Market Size by Type
6.1.1 North America Micafungin Drug Sales by Type (2016-2027)
6.1.2 North America Micafungin Drug Revenue by Type (2016-2027)
6.2 North America Micafungin Drug Market Size by Application
6.2.1 North America Micafungin Drug Sales by Application (2016-2027)
6.2.2 North America Micafungin Drug Revenue by Application (2016-2027)
6.3 North America Micafungin Drug Market Size by Country
6.3.1 North America Micafungin Drug Sales by Country (2016-2027)
6.3.2 North America Micafungin Drug Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Micafungin Drug Market Size by Type
7.1.1 Europe Micafungin Drug Sales by Type (2016-2027)
7.1.2 Europe Micafungin Drug Revenue by Type (2016-2027)
7.2 Europe Micafungin Drug Market Size by Application
7.2.1 Europe Micafungin Drug Sales by Application (2016-2027)
7.2.2 Europe Micafungin Drug Revenue by Application (2016-2027)
7.3 Europe Micafungin Drug Market Size by Country
7.3.1 Europe Micafungin Drug Sales by Country (2016-2027)
7.3.2 Europe Micafungin Drug Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Micafungin Drug Market Size by Type
8.1.1 Asia Pacific Micafungin Drug Sales by Type (2016-2027)
8.1.2 Asia Pacific Micafungin Drug Revenue by Type (2016-2027)
8.2 Asia Pacific Micafungin Drug Market Size by Application
8.2.1 Asia Pacific Micafungin Drug Sales by Application (2016-2027)
8.2.2 Asia Pacific Micafungin Drug Revenue by Application (2016-2027)
8.3 Asia Pacific Micafungin Drug Market Size by Region
8.3.1 Asia Pacific Micafungin Drug Sales by Region (2016-2027)
8.3.2 Asia Pacific Micafungin Drug Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Micafungin Drug Market Size by Type
9.1.1 Latin America Micafungin Drug Sales by Type (2016-2027)
9.1.2 Latin America Micafungin Drug Revenue by Type (2016-2027)
9.2 Latin America Micafungin Drug Market Size by Application
9.2.1 Latin America Micafungin Drug Sales by Application (2016-2027)
9.2.2 Latin America Micafungin Drug Revenue by Application (2016-2027)
9.3 Latin America Micafungin Drug Market Size by Country
9.3.1 Latin America Micafungin Drug Sales by Country (2016-2027)
9.3.2 Latin America Micafungin Drug Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Micafungin Drug Market Size by Type
10.1.1 Middle East and Africa Micafungin Drug Sales by Type (2016-2027)
10.1.2 Middle East and Africa Micafungin Drug Revenue by Type (2016-2027)
10.2 Middle East and Africa Micafungin Drug Market Size by Application
10.2.1 Middle East and Africa Micafungin Drug Sales by Application (2016-2027)
10.2.2 Middle East and Africa Micafungin Drug Revenue by Application (2016-2027)
10.3 Middle East and Africa Micafungin Drug Market Size by Country
10.3.1 Middle East and Africa Micafungin Drug Sales by Country (2016-2027)
10.3.2 Middle East and Africa Micafungin Drug Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Astellas
11.1.1 Astellas Corporation Information
11.1.2 Astellas Overview
11.1.3 Astellas Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Astellas Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astellas Recent Developments
11.2 Endo International
11.2.1 Endo International Corporation Information
11.2.2 Endo International Overview
11.2.3 Endo International Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Endo International Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Endo International Recent Developments
11.3 Xellia Pharmaceuticals
11.3.1 Xellia Pharmaceuticals Corporation Information
11.3.2 Xellia Pharmaceuticals Overview
11.3.3 Xellia Pharmaceuticals Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Xellia Pharmaceuticals Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Xellia Pharmaceuticals Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Teva Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Hikma
11.5.1 Hikma Corporation Information
11.5.2 Hikma Overview
11.5.3 Hikma Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Hikma Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Recent Developments
11.6 Jiangsu Hansoh Pharmaceutical
11.6.1 Jiangsu Hansoh Pharmaceutical Corporation Information
11.6.2 Jiangsu Hansoh Pharmaceutical Overview
11.6.3 Jiangsu Hansoh Pharmaceutical Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Jiangsu Hansoh Pharmaceutical Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments
11.7 Apotex
11.7.1 Apotex Corporation Information
11.7.2 Apotex Overview
11.7.3 Apotex Micafungin Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Apotex Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Apotex Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Micafungin Drug Value Chain Analysis
12.2 Micafungin Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Micafungin Drug Production Mode & Process
12.4 Micafungin Drug Sales and Marketing
12.4.1 Micafungin Drug Sales Channels
12.4.2 Micafungin Drug Distributors
12.5 Micafungin Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Micafungin Drug Industry Trends
13.2 Micafungin Drug Market Drivers
13.3 Micafungin Drug Market Challenges
13.4 Micafungin Drug Market Restraints
14 Key Findings in The Global Micafungin Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Micafungin Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 50 mg Single-use Vial
Table 3. Major Manufacturers of 100 mg Single-use Vial
Table 4. Global Micafungin Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Micafungin Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Micafungin Drug Sales by Region (2016-2021) & (K Units)
Table 7. Global Micafungin Drug Sales Market Share by Region (2016-2021)
Table 8. Global Micafungin Drug Sales by Region (2022-2027) & (K Units)
Table 9. Global Micafungin Drug Sales Market Share by Region (2022-2027)
Table 10. Global Micafungin Drug Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Micafungin Drug Revenue Market Share by Region (2016-2021)
Table 12. Global Micafungin Drug Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Micafungin Drug Revenue Market Share by Region (2022-2027)
Table 14. Global Micafungin Drug Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Micafungin Drug Sales Share by Manufacturers (2016-2021)
Table 16. Global Micafungin Drug Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Micafungin Drug Revenue Share by Manufacturers (2016-2021)
Table 18. Micafungin Drug Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Micafungin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Micafungin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micafungin Drug as of 2020)
Table 21. Micafungin Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Micafungin Drug Product Offered
Table 23. Date of Manufacturers Enter into Micafungin Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Micafungin Drug Sales by Type (2016-2021) & (K Units)
Table 26. Global Micafungin Drug Sales by Type (2022-2027) & (K Units)
Table 27. Global Micafungin Drug Sales Share by Type (2016-2021)
Table 28. Global Micafungin Drug Sales Share by Type (2022-2027)
Table 29. Global Micafungin Drug Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Micafungin Drug Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Micafungin Drug Revenue Share by Type (2016-2021)
Table 32. Global Micafungin Drug Revenue Share by Type (2022-2027)
Table 33. Micafungin Drug Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Micafungin Drug Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Micafungin Drug Sales by Application (2016-2021) & (K Units)
Table 36. Global Micafungin Drug Sales by Application (2022-2027) & (K Units)
Table 37. Global Micafungin Drug Sales Share by Application (2016-2021)
Table 38. Global Micafungin Drug Sales Share by Application (2022-2027)
Table 39. Global Micafungin Drug Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Micafungin Drug Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Micafungin Drug Revenue Share by Application (2016-2021)
Table 42. Global Micafungin Drug Revenue Share by Application (2022-2027)
Table 43. Micafungin Drug Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Micafungin Drug Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Micafungin Drug Sales by Type (2016-2021) & (K Units)
Table 46. North America Micafungin Drug Sales by Type (2022-2027) & (K Units)
Table 47. North America Micafungin Drug Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Micafungin Drug Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Micafungin Drug Sales by Application (2016-2021) & (K Units)
Table 50. North America Micafungin Drug Sales by Application (2022-2027) & (K Units)
Table 51. North America Micafungin Drug Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Micafungin Drug Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Micafungin Drug Sales by Country (2016-2021) & (K Units)
Table 54. North America Micafungin Drug Sales by Country (2022-2027) & (K Units)
Table 55. North America Micafungin Drug Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Micafungin Drug Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Micafungin Drug Sales by Type (2016-2021) & (K Units)
Table 58. Europe Micafungin Drug Sales by Type (2022-2027) & (K Units)
Table 59. Europe Micafungin Drug Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Micafungin Drug Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Micafungin Drug Sales by Application (2016-2021) & (K Units)
Table 62. Europe Micafungin Drug Sales by Application (2022-2027) & (K Units)
Table 63. Europe Micafungin Drug Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Micafungin Drug Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Micafungin Drug Sales by Country (2016-2021) & (K Units)
Table 66. Europe Micafungin Drug Sales by Country (2022-2027) & (K Units)
Table 67. Europe Micafungin Drug Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Micafungin Drug Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Micafungin Drug Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Micafungin Drug Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Micafungin Drug Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Micafungin Drug Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Micafungin Drug Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Micafungin Drug Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Micafungin Drug Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Micafungin Drug Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Micafungin Drug Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Micafungin Drug Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Micafungin Drug Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Micafungin Drug Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Micafungin Drug Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Micafungin Drug Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Micafungin Drug Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Micafungin Drug Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Micafungin Drug Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Micafungin Drug Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Micafungin Drug Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Micafungin Drug Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Micafungin Drug Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Micafungin Drug Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Micafungin Drug Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Micafungin Drug Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Micafungin Drug Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Micafungin Drug Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Micafungin Drug Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Micafungin Drug Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Micafungin Drug Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Micafungin Drug Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Micafungin Drug Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Micafungin Drug Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Micafungin Drug Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Micafungin Drug Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Micafungin Drug Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Micafungin Drug Revenue by Country (2022-2027) & (US$ Million)
Table 105. Astellas Corporation Information
Table 106. Astellas Description and Major Businesses
Table 107. Astellas Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Astellas Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Astellas Recent Developments
Table 110. Endo International Corporation Information
Table 111. Endo International Description and Major Businesses
Table 112. Endo International Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Endo International Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Endo International Recent Developments
Table 115. Xellia Pharmaceuticals Corporation Information
Table 116. Xellia Pharmaceuticals Description and Major Businesses
Table 117. Xellia Pharmaceuticals Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Xellia Pharmaceuticals Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Xellia Pharmaceuticals Recent Developments
Table 120. Teva Corporation Information
Table 121. Teva Description and Major Businesses
Table 122. Teva Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Teva Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Teva Recent Developments
Table 125. Hikma Corporation Information
Table 126. Hikma Description and Major Businesses
Table 127. Hikma Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Hikma Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Hikma Recent Developments
Table 130. Jiangsu Hansoh Pharmaceutical Corporation Information
Table 131. Jiangsu Hansoh Pharmaceutical Description and Major Businesses
Table 132. Jiangsu Hansoh Pharmaceutical Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Jiangsu Hansoh Pharmaceutical Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Jiangsu Hansoh Pharmaceutical Recent Developments
Table 135. Apotex Corporation Information
Table 136. Apotex Description and Major Businesses
Table 137. Apotex Micafungin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Apotex Micafungin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Apotex Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Micafungin Drug Distributors List
Table 143. Micafungin Drug Customers List
Table 144. Micafungin Drug Market Trends
Table 145. Micafungin Drug Market Drivers
Table 146. Micafungin Drug Market Challenges
Table 147. Micafungin Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Micafungin Drug Product Picture
Figure 3. Global Micafungin Drug Market Share by Type in 2020 & 2027
Figure 3. 50 mg Single-use Vial Product Picture
Figure 4. 100 mg Single-use Vial Product Picture
Figure 5. Global Micafungin Drug Market Share by Application in 2020 & 2027
Figure 6. Candidemia
Figure 7. Respiratory Mycosis
Figure 8. Gastrointestinal Mycosis
Figure 9. Micafungin Drug Report Years Considered
Figure 10. Global Micafungin Drug Sales 2016-2027 (K Units)
Figure 11. Global Micafungin Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Micafungin Drug Revenue 2016-2027 (US$ Million)
Figure 13. Global Micafungin Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Micafungin Drug Sales Market Share by Region (2016-2021)
Figure 15. Global Micafungin Drug Sales Market Share by Region (2022-2027)
Figure 16. North America Micafungin Drug Sales YoY (2016-2027) & (K Units)
Figure 17. North America Micafungin Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Micafungin Drug Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Micafungin Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Micafungin Drug Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Micafungin Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Micafungin Drug Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Micafungin Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Micafungin Drug Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Micafungin Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Micafungin Drug Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Micafungin Drug Revenue in 2020
Figure 28. Micafungin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Micafungin Drug Sales Market Share by Type (2016-2027)
Figure 30. Global Micafungin Drug Revenue Market Share by Type (2016-2027)
Figure 31. Global Micafungin Drug Sales Market Share by Application (2016-2027)
Figure 32. Global Micafungin Drug Revenue Market Share by Application (2016-2027)
Figure 33. North America Micafungin Drug Sales Market Share by Type (2016-2027)
Figure 34. North America Micafungin Drug Revenue Market Share by Type (2016-2027)
Figure 35. North America Micafungin Drug Sales Market Share by Application (2016-2027)
Figure 36. North America Micafungin Drug Revenue Market Share by Application (2016-2027)
Figure 37. North America Micafungin Drug Sales Share by Country (2016-2027)
Figure 38. North America Micafungin Drug Revenue Share by Country (2016-2027)
Figure 39. United States Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Micafungin Drug Sales Market Share by Type (2016-2027)
Figure 42. Europe Micafungin Drug Revenue Market Share by Type (2016-2027)
Figure 43. Europe Micafungin Drug Sales Market Share by Application (2016-2027)
Figure 44. Europe Micafungin Drug Revenue Market Share by Application (2016-2027)
Figure 45. Europe Micafungin Drug Sales Share by Country (2016-2027)
Figure 46. Europe Micafungin Drug Revenue Share by Country (2016-2027)
Figure 47. Germany Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 48. France Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Micafungin Drug Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Micafungin Drug Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Micafungin Drug Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Micafungin Drug Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Micafungin Drug Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Micafungin Drug Revenue Share by Region (2016-2027)
Figure 58. China Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 61. India Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Micafungin Drug Sales Market Share by Type (2016-2027)
Figure 68. Latin America Micafungin Drug Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Micafungin Drug Sales Market Share by Application (2016-2027)
Figure 70. Latin America Micafungin Drug Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Micafungin Drug Sales Share by Country (2016-2027)
Figure 72. Latin America Micafungin Drug Revenue Share by Country (2016-2027)
Figure 73. Mexico Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Micafungin Drug Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Micafungin Drug Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Micafungin Drug Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Micafungin Drug Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Micafungin Drug Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Micafungin Drug Revenue Share by Country (2016-2027)
Figure 83. Turkey Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Micafungin Drug Revenue (2016-2027) & (US$ Million)
Figure 86. Micafungin Drug Value Chain
Figure 87. Micafungin Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
ミカファンギンナトリウム薬剤のグローバル市場インサイト・予測（～2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. Market Analysis and Insights: Global Micafungin Sodium Drug Market The global Micafungin Sodium Drug market is valued a…- パラセタモール薬のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Paracetamol Drug Market The global Paracetamol Drug market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Paracetamol Drug Scope and Segment Paracetamol Drug mar…
- ニタゾキサニド薬品のグローバル市場インサイト・予測（～2027年） Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Market Analysis and Insights: Global Nitazoxanide Drug Market The globa…
- プロプラノロール薬のグローバル市場インサイト・予測（～2027年） Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migrain…
- 注射薬包装のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Injectable Drug Packaging Market The global Injectable Drug Packaging market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Injectable Drug Packaging Scope and Segment I…